Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective neutralizing epitopes in SARS‐CoV‐2
Hejun Liu, Ian A. Wilson
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 76-92
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
Pan-Pan Zhou, Ge Song, Hejun Liu, et al.
Immunity (2023) Vol. 56, Iss. 3, pp. 669-686.e7
Open Access | Times Cited: 117
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
Dennis Lapuente, Thomas Winkler, Matthias Tenbusch
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 144-158
Open Access | Times Cited: 35
SARS-CoV-2 spike S2-specific neutralizing antibodies
Chia‐Jung Li, Shih‐Chung Chang
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 33
Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike
Timothy J.C. Tan, Abhishek Kumar Verma, Abby Odle, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 15
Open Access | Times Cited: 8
Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants including the emerging EG.5 lineages
Ling Li, Xixian Chen, Zuowei Wang, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 12, pp. e1011856-e1011856
Open Access | Times Cited: 16
Amino Acids Frequency and Interaction Trends: Comprehensive Analysis of Experimentally Validated Viral Antigen–Antibody Complexes
Roylan Pais, Anil Kumar Nagraj, Riya Patel, et al.
Molecular Biotechnology (2025)
Closed Access
Neutralising and Non-neutralising Antibodies to SARS-CoV-2: Role during Infection and in the Evolution of Antigenic structure
S. K. Pylaeva, A. A. Sinyugina, Liubov I. Kozlovskaya, et al.
Epidemiology and Vaccinal Prevention (2025) Vol. 23, Iss. 6, pp. 169-176
Open Access
SARS-CoV-2 spike protein is a self-adjuvanted antigen for mucosal immunization and confers broad protection against lethal challenge with SARS-CoV-2 via intranasal vaccination
Ping Zhao, Zhendong Pan, Zheng Xu, et al.
Research Square (Research Square) (2025)
Closed Access
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
Siriruk Changrob, Peter Halfmann, Hejun Liu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 8
Open Access | Times Cited: 12
Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift
Ge Song, Meng Yuan, Hejun Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Defining neutralization and allostery by antibodies against COVID-19 variants
Nikhil Kumar Tulsian, Raghuvamsi Venkata Palur, Xinlei Qian, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves
Han Di, Elizabeth A. Pusch, Joyce Jones, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 505-505
Open Access | Times Cited: 3
Massively-multiplexed epitope mapping techniques for viral antigen discovery
Diya Hu, Aaron T. Irving
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Cumulative incidence of SARS‐CoV‐2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant
Jorge Camacho, Estela Giménez, Eliseo Albert, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 13
SARS-CoV-2 epitopes inform future vaccination strategies
Areez Shafqat, Mohamed H. Omer, Omar Ahmad, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine
Xiaorui Chen, Arpita Mohapatra, Hong Thuy Vy Nguyen, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 6, pp. e1012246-e1012246
Open Access | Times Cited: 2
HLA-I and HLA-II Peptidomes of SARS-CoV-2: A Review
Nawal Abd El‐Baky, Amro Abd Al Fattah Amara, Elrashdy M. Redwan
Vaccines (2023) Vol. 11, Iss. 3, pp. 548-548
Open Access | Times Cited: 5
Risk assessment of SARS-CoV-2 replicating and evolving in animals
Jin Zhao, Mei Kang, Hongyan Wu, et al.
Trends in Microbiology (2023) Vol. 32, Iss. 1, pp. 79-92
Open Access | Times Cited: 5
Development of a bispecific nanobody conjugate broadly neutralizes diverse SARS-CoV-2 variants and structural basis for its broad neutralization
Jing Yang, Sheng Lin, Zimin Chen, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011804-e1011804
Open Access | Times Cited: 5
Innovations and Challenges in the Development of COVID-19 Vaccines for a Safer Tomorrow
Devika Sanil Kumar, Krishna Prasanth Baalann, A Bhandari, et al.
Cureus (2024)
Open Access | Times Cited: 1
Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium
Laura Marcos-Villar, Beatriz Perdiguero, Marı́a López-Bravo, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Neutralizing Antibody Spectrum in COVID-19 Patients who Became Ill During the Circulation of Different SARS-CoV-2 Variants
S. K. Pylaeva, Liubov I. Kozlovskaya, А. A. Erovichenkov, et al.
Epidemiology and Vaccinal Prevention (2024) Vol. 23, Iss. 5, pp. 63-72
Open Access | Times Cited: 1
A performance comparison of two (electro) chemiluminescence immunoassays for detection and quantitation of serum anti‐spike antibodies according to SARS‐CoV‐2 vaccination and infections status
Jorge Camacho, Eliseo Albert, João Zulaica, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 7
Development of an ELISA Assay for the Determination of SARS-CoV-2 Protein Subunit Vaccine Antigen Content
Lu Han, Chaoqiang An, Dong Liu, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 62-62
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top